Company / Assets per Share
Jade Biosciences, Inc. Assets per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.81
FY2024
5-year range
$2.81 / $19.46
FY2020-FY2024
Trend
-41.9%
vs FY2023
Sector context
#174 of 208
Health Care
What the data says
Jade Biosciences, Inc.'s assets per share of $2.81 is lower than 84% of companies in the Health Care sector (FY2024). Assets per Share has declined for 4 consecutive years, from $19.46 in FY2020 to $2.81 in FY2024.
Based on SEC 10-K filings.
2.81 in FY2024 with a 3-year CAGR of -41.8%.
Declined from $5.53 to $2.81 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -41.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 208This company $2.81 Sector average $377.57
▼
-99.3% below sector average
Key checks
Key Insights
- Jade Biosciences, Inc.'s assets per share has declined for 4 consecutive years.
- In FY2024, assets per share decreased 41.9% year-over-year.
- Ranks #174 out of 208 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.81 | -41.9% |
| FY2023 | $4.84 | -12.5% |
| FY2022 | $5.53 | -61.2% |
| FY2021 | $14.26 | -26.7% |
| FY2020 | $19.46 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026